Gene · 11277
Papers2,317
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,317
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytosolic DNA accumulation promotes breast cancer immunogenicity via a STING-independent pathway. | J Immunother Cancer | 2023 | 37907220 | PubTator, text mining | PubMed |
| Phase Separation in Kidney Diseases: Autosomal Dominant Polycystic Kidney Disease and Beyond. | Kidney Dis (Basel) | 2023 | 37899998 | PubTator, text mining | PubMed |
| Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease. | Cells | 2023 | 37887346 | PubTator, text mining | PubMed |
| Investigation of immune-related diseases using patient-derived induced pluripotent stem cells. | Inflamm Regen | 2023 | 37876023 | PubTator, text mining | PubMed |
| Molecular insight into the specific enzymatic properties of TREX1 revealing the diverse functions in processing RNA and DNA/RNA hybrids. | Nucleic Acids Res | 2023 | 37870446 | PubTator, text mining | PubMed |
| Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. | Oncogene | 2023 | 37864030 | PubTator, text mining | PubMed |
| Unprecedented reactivity of polyamines with aldehydic DNA modifications: structural determinants of reactivity, characterization and enzymatic stability of adducts. | Nucleic Acids Res | 2023 | 37850658 | PubTator, text mining | PubMed |
| Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-Genetic Analysis. | Kidney Int Rep | 2023 | 37850010 | PubTator, text mining | PubMed |
| Kidney-Predominant Thrombotic Microangiopathy Associated With TREX1 Frameshift Mutation. | Kidney Int Rep | 2023 | 37850007 | PubTator, text mining | PubMed |
| Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer. | Br J Cancer | 2023 | 37838813 | PubTator, text mining | PubMed |
| The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis. | Int J Mol Sci | 2023 | 37834346 | PubTator, text mining | PubMed |
| How Does cGAS Avoid Sensing Self-DNA under Normal Physiological Conditions? | Int J Mol Sci | 2023 | 37834184 | PubTator, text mining | PubMed |
| Senescent Cells: Dual Implications on the Retinal Vascular System. | Cells | 2023 | 37830555 | PubTator, text mining | PubMed |
| Case report: Recurrent pontine stroke and leukoencephalopathy in a patient with de novo mutation in COL4A1. | Front Neurol | 2023 | 37830085 | PubTator, text mining | PubMed |
| Tocilizumab reduces the unmanageable inflammatory reaction of a patient with Aicardi-Goutières syndrome type 7 during treatment with ruxolitinib. | Pediatr Rheumatol Online J | 2023 | 37828538 | PubTator, text mining | PubMed |
| Nucleotide Excision Repair of Aflatoxin-induced DNA Damage within the 3D Human Genome Organization. | bioRxiv | 2023 | 37808841 | PubTator, text mining | PubMed |
| Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separation. | Nat Commun | 2023 | 37783727 | PubTator, text mining | PubMed |
| Innate immune response restarts adaptive immune response in tumors. | Front Immunol | 2023 | 37781382 | PubTator, text mining | PubMed |
| Updated roles of cGAS-STING signaling in autoimmune diseases. | Front Immunol | 2023 | 37781360 | PubTator, text mining | PubMed |
| cGAS-STING signaling pathway in intestinal homeostasis and diseases. | Front Immunol | 2023 | 37781354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11277/papers?page=12